Table 1 Patient characteristics and features of chronic graft-versus-host disease flare.
From: Chronic graft-versus-host disease exacerbation after SARS-CoV-2 vaccination
Patient | Age | On prednisone at time of flare | Days to flare after dose #1 | Days to flare after dose #2 | Days between transplant and flare | Flare organ | Flare severity organ upstaging | Oral systemic therapy added | Topical therapy added |
|---|---|---|---|---|---|---|---|---|---|
1 | 61 | No | 1 | N/A | 965 | Skin | 1 | Yes | No |
Mouth | |||||||||
Esophagus | |||||||||
2 | 73 | No | 22 | 1 | 2907 | Skin | 1 | No | Yes |
Mouth | |||||||||
3 | 68 | No | 48 | 27 | 445 | Skin | 1-2 | No | Yes |
Mouth | |||||||||
Eyes | |||||||||
Liver | |||||||||
4 | 49 | No | 1 | N/A | 1221 | Liver | 1 | Yes | No |
5 | 63 | No | 17 | N/A | 346 | Skin | 1 | Yes | No |
Joints | |||||||||
6 | 58 | Yes | 28 | 1 | 350 | Skin | 1 | Yes | Yes |
Mouth | |||||||||
Eyes | |||||||||
Joints | |||||||||
7 | 41 | No | 26 | 5 | 2393 | Skin | 1 | Yes | No |
8 | 69 | No | 29 | 1 | 1652 | Mouth | 1 | No | Yes |
Eyes | |||||||||
9 | 36 | Yes | 24 | 2 | 719 | Mouth | 2 | Yes | No |
Eyes |
